MEDITE Cancer Diagnostics Inc – Strategy, SWOT and Corporate Finance Report
- Pages: 42
- Published: August 2018
- Report Code: MLME229FSA
MEDITE Cancer Diagnostics Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrasonic decalcification instruments, tissue processing instruments, freezing microtome, cryostats, linear staining systems, staining systems, and cytology screening systems. The company’s products find application in processing tissue, cell collection ranging from processing to diagnosis. These devices and consumables are manufactured at is facility in Burgdorf, Germany. The company sells its products through a direct sale force located in Germany, Poland and the US, and also through independent distributors. MEDITE is headquartered in Orlando, Florida, the US.
Scope
Detailed information on MEDITE Cancer Diagnostics Inc required for business and competitor intelligence needs
A study of the major internal and external factors affecting MEDITE Cancer Diagnostics Inc in the form of a SWOT analysis
An in-depth view of the business model of MEDITE Cancer Diagnostics Inc including a breakdown and examination of key business segments
News about MEDITE Cancer Diagnostics Inc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of MEDITE Cancer Diagnostics Inc and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess MEDITE Cancer Diagnostics Inc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on MEDITE Cancer Diagnostics Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Cytyc Surgical Products
Dako A/S
Leica Biosystems Nussloch Gmbh
Sakura Finetek USA, Inc.
Thermo Fisher Scientific Inc
TriPath Imaging Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.